Skip to main content
Erschienen in: Osteoporosis International 6/2011

01.06.2011 | Original Article

Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture

verfasst von: S. R. Majumdar, D. A. Lier, B. H. Rowe, A. S. Russell, F. A. McAlister, W. P. Maksymowych, D. A. Hanley, D. W. Morrish, J. A. Johnson

Erschienen in: Osteoporosis International | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Summary

In a randomized trial, a multifaceted intervention tripled rates of osteoporosis treatment in older patients with wrist fracture. An economic analysis of the trial now demonstrates that the intervention tested “dominates” usual care: over a lifetime horizon, it reduces fracture, increases quality-adjusted life years, and saves the healthcare system money.

Introduction

In a randomized trial (N = 272), we reported a multifaceted quality improvement intervention directed at older patients and their physicians could triple rates of osteoporosis treatment within 6 months of a wrist fracture when compared with usual care (22% vs 7%). Alongside the trial, we conducted an economic evaluation.

Methods

Using 1-year outcome data from our trial and micro-costing time-motion studies, we constructed a Markov decision-analytic model to determine cost-effectiveness of the intervention compared with usual care over the patients’ remaining lifetime. We took the perspective of third-party healthcare payers. In the base case, costs and benefits were discounted at 3% and expressed in 2006 Canadian dollars. One-way deterministic and probabilistic sensitivity analyses were conducted.

Results

Median age of patients was 60 years, 77% were women, and 72% had low bone mineral density (BMD). The intervention cost $12 per patient. Compared with usual care, the intervention strategy was dominant: for every 100 patients receiving the intervention, three fractures (one hip fracture) would be prevented, 1.1 quality-adjusted life year gained, and $26,800 saved by the healthcare system over their remaining lifetime. The intervention dominated usual care across numerous one-way sensitivity analyses: with respect to cost, the most influential parameter was drug price; in terms of effectiveness, the most influential parameter was rate of BMD testing. The intervention was cost saving in 80% of probabilistic model simulations.

Conclusions

For outpatients with wrist fractures, our multifaceted osteoporosis intervention was cost-effective. Healthcare systems implementing similar interventions should expect to save money, reduce fractures, and gain quality-adjusted life expectancy.
Literatur
1.
Zurück zum Zitat Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475PubMedCrossRef Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475PubMedCrossRef
3.
Zurück zum Zitat Scientific Advisory Council, Osteoporosis Society of Canada (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(suppl):S1–S34 Scientific Advisory Council, Osteoporosis Society of Canada (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(suppl):S1–S34
4.
Zurück zum Zitat Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA et al (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178(5):569–575PubMed Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA et al (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178(5):569–575PubMed
5.
Zurück zum Zitat Majumdar SR, Johnson JA, Lier DA et al (2007) Persistence reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int 18:261–270PubMedCrossRef Majumdar SR, Johnson JA, Lier DA et al (2007) Persistence reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int 18:261–270PubMedCrossRef
6.
Zurück zum Zitat Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG et al (2009) Osteoporosis case-manager for hip fracture patients: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169(1):25–31PubMedCrossRef Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG et al (2009) Osteoporosis case-manager for hip fracture patients: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169(1):25–31PubMedCrossRef
7.
Zurück zum Zitat Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BR, Morrish DW et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141:366–373PubMed Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BR, Morrish DW et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141:366–373PubMed
8.
Zurück zum Zitat Bessette L, Ste-Marie LG, Jean S, Davison KS, Beaulieu M et al (2008) The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 19:79–86PubMedCrossRef Bessette L, Ste-Marie LG, Jean S, Davison KS, Beaulieu M et al (2008) The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 19:79–86PubMedCrossRef
9.
Zurück zum Zitat Sonnenberg F, Beck R (1993) Markov models in Medical Decision-making: a practical guide. Med Decis Mak 13(4):322–338CrossRef Sonnenberg F, Beck R (1993) Markov models in Medical Decision-making: a practical guide. Med Decis Mak 13(4):322–338CrossRef
10.
Zurück zum Zitat Tosteson AN, Jonsson B, Grima DT, O’Brien BJ, Black DM, Adachi JD (2001) Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int 12:849–857PubMedCrossRef Tosteson AN, Jonsson B, Grima DT, O’Brien BJ, Black DM, Adachi JD (2001) Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int 12:849–857PubMedCrossRef
11.
Zurück zum Zitat Johnell O, Jšnsson B, Jšnsson L, Black D (2003) Cost effectiveness of alendronate for the treatment of osteoporosis and prevention of fractures. PharmacoEconomics 21:305–314PubMedCrossRef Johnell O, Jšnsson B, Jšnsson L, Black D (2003) Cost effectiveness of alendronate for the treatment of osteoporosis and prevention of fractures. PharmacoEconomics 21:305–314PubMedCrossRef
12.
Zurück zum Zitat Zethraeus N, Borgstršm F, Stršm O, Kanis J, Jšnsson B (2007) Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporos Int 18:9–23PubMedCrossRef Zethraeus N, Borgstršm F, Stršm O, Kanis J, Jšnsson B (2007) Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporos Int 18:9–23PubMedCrossRef
13.
Zurück zum Zitat Strom O, Zethraeus N, Borgstršm F, Johnell O, Jšnsson B, Kanis J. IOF cost-effectiveness reference model: background document. International Osteoporosis Foundation. Available at: http://www.iofbonehealth.org. Accessed 5 March 2010 Strom O, Zethraeus N, Borgstršm F, Johnell O, Jšnsson B, Kanis J. IOF cost-effectiveness reference model: background document. International Osteoporosis Foundation. Available at: http://​www.​iofbonehealth.​org. Accessed 5 March 2010
14.
Zurück zum Zitat Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef
15.
Zurück zum Zitat Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271–278PubMedCrossRef Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271–278PubMedCrossRef
16.
Zurück zum Zitat Cranney A, Guyatt GH, Griffith L, Wells G, Tugwell P, for the Osteoporosis Research Advisory Group (2002) IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocrinol Rev 23:570–578CrossRef Cranney A, Guyatt GH, Griffith L, Wells G, Tugwell P, for the Osteoporosis Research Advisory Group (2002) IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocrinol Rev 23:570–578CrossRef
17.
Zurück zum Zitat Tonino RP, Meunier PJ, Emkey RD, Rodriguez-Portales JA, Menkes CJ, Wasnich RD et al (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. J Clin Endocrinol Metab 85:3109–3115PubMedCrossRef Tonino RP, Meunier PJ, Emkey RD, Rodriguez-Portales JA, Menkes CJ, Wasnich RD et al (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. J Clin Endocrinol Metab 85:3109–3115PubMedCrossRef
18.
Zurück zum Zitat Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD et al (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189–1199PubMedCrossRef Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD et al (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189–1199PubMedCrossRef
19.
Zurück zum Zitat Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM et al (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419PubMedCrossRef Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM et al (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419PubMedCrossRef
20.
Zurück zum Zitat Schousboe JT, Nyman JA, Kane RL, Ensrud KE (2005) Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 142:734–741PubMed Schousboe JT, Nyman JA, Kane RL, Ensrud KE (2005) Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 142:734–741PubMed
21.
Zurück zum Zitat Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, et al (2010) Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int doi:10.1007/s00198-010-1212-7 Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, et al (2010) Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int doi:10.​1007/​s00198-010-1212-7
22.
Zurück zum Zitat Alberta Health Care Insurance Plan (2006) Schedule of medical benefits (procedures and price list). Alberta Health Care, Edmonton, Alberta, Canada Alberta Health Care Insurance Plan (2006) Schedule of medical benefits (procedures and price list). Alberta Health Care, Edmonton, Alberta, Canada
23.
Zurück zum Zitat Alberta Health and Wellness (2007) Drug benefits list. Alberta Health and Wellness, Edmonton, Alberta, Canada Alberta Health and Wellness (2007) Drug benefits list. Alberta Health and Wellness, Edmonton, Alberta, Canada
24.
Zurück zum Zitat Alberta Health and Wellness (2006) Health Costing in Alberta - Annual Report. Edmonton, Alberta, Canada Alberta Health and Wellness (2006) Health Costing in Alberta - Annual Report. Edmonton, Alberta, Canada
25.
Zurück zum Zitat Canadian Institute for Health Information (2006) Resource intensity weights and expected length of stay. Canadian Institute for Health Information, Ottawa, Ontario, Canada Canadian Institute for Health Information (2006) Resource intensity weights and expected length of stay. Canadian Institute for Health Information, Ottawa, Ontario, Canada
26.
Zurück zum Zitat Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7:221–227PubMedCrossRef Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7:221–227PubMedCrossRef
27.
Zurück zum Zitat Statistics Canada (2006) Life tables—Canada, provinces and territories, 2000–2002 (84–537-XIE). Statistics Canada, Ottawa, Ontario, Canada Statistics Canada (2006) Life tables—Canada, provinces and territories, 2000–2002 (84–537-XIE). Statistics Canada, Ottawa, Ontario, Canada
28.
Zurück zum Zitat Peasgood T, Herrmann K, Kanis JA, Brazier JE (2009) An updated systematic review of health state utility values for osteoporosis related conditions. Osteoporos Int 20:853–868PubMedCrossRef Peasgood T, Herrmann K, Kanis JA, Brazier JE (2009) An updated systematic review of health state utility values for osteoporosis related conditions. Osteoporos Int 20:853–868PubMedCrossRef
29.
Zurück zum Zitat Koopmanschap MA, Rutten FFH (1996) A practical guide for calculating indirect costs of disease. PharmacoEconomics 10(5):460–466PubMedCrossRef Koopmanschap MA, Rutten FFH (1996) A practical guide for calculating indirect costs of disease. PharmacoEconomics 10(5):460–466PubMedCrossRef
30.
Zurück zum Zitat Statistics Canada (2009) Labour force survey estimates (LFS)—wages of employees by type of work, National Occupational Classification for Statistics (NOC-S), sex and age group, unadjusted for seasonality, computed annual average (Table 282-0069). Statistics Canada, Ottawa, Ontario, Canada Statistics Canada (2009) Labour force survey estimates (LFS)—wages of employees by type of work, National Occupational Classification for Statistics (NOC-S), sex and age group, unadjusted for seasonality, computed annual average (Table 282-0069). Statistics Canada, Ottawa, Ontario, Canada
31.
Zurück zum Zitat Dong H, Buxton M (2006) Early assessment of the likely cost-effectiveness of a new technology: a Markov model with probabilistic sensitivity analysis of computer-assisted knee replacement. Int J Technol Assess Health Care 22:191–202PubMedCrossRef Dong H, Buxton M (2006) Early assessment of the likely cost-effectiveness of a new technology: a Markov model with probabilistic sensitivity analysis of computer-assisted knee replacement. Int J Technol Assess Health Care 22:191–202PubMedCrossRef
32.
Zurück zum Zitat Donaldson C, Currie G, Mitton C (2002) Cost-effectiveness analysis in healthcare: contraindications. BMJ 325:891–894PubMedCrossRef Donaldson C, Currie G, Mitton C (2002) Cost-effectiveness analysis in healthcare: contraindications. BMJ 325:891–894PubMedCrossRef
33.
Zurück zum Zitat Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809PubMedCrossRef Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809PubMedCrossRef
34.
Zurück zum Zitat MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V et al (2008) Systematic review: comparative effectiveness of treatments to prevent fracture in men and women with low bone density or osteoporosis. Ann Intern Med 148:197–213PubMed MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V et al (2008) Systematic review: comparative effectiveness of treatments to prevent fracture in men and women with low bone density or osteoporosis. Ann Intern Med 148:197–213PubMed
35.
Zurück zum Zitat Majumdar SR (2008) Recent trends in osteoporosis treatment after hip fracture: improving but wholly inadequate. J Rheum 35:190–193PubMed Majumdar SR (2008) Recent trends in osteoporosis treatment after hip fracture: improving but wholly inadequate. J Rheum 35:190–193PubMed
Metadaten
Titel
Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture
verfasst von
S. R. Majumdar
D. A. Lier
B. H. Rowe
A. S. Russell
F. A. McAlister
W. P. Maksymowych
D. A. Hanley
D. W. Morrish
J. A. Johnson
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 6/2011
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-010-1412-1

Weitere Artikel der Ausgabe 6/2011

Osteoporosis International 6/2011 Zur Ausgabe

Bone Quality Seminars: Bone Fracture Healing and Strengthening

Bone fracture and bone fracture repair

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.